Potassium homeostasis and clinical implications.

Area of Science:

• Nephrology
• Endocrinology
• Clinical Medicine

Background:

• Clinical potassium balance assessment relies heavily on serum potassium levels, which represent only a small fraction of total body potassium.
• Significant total body potassium deficits may not manifest as hypokalemia, while minor excesses can cause hyperkalemia.
• Potassium distribution between intracellular and extracellular compartments significantly impacts serum levels independently of total body potassium.

Purpose of the Study:

• To highlight the limitations of serum potassium in reflecting total body potassium status.
• To elucidate the complex mechanisms regulating potassium homeostasis, including renal excretion and cellular distribution.
• To emphasize the clinical significance of understanding drug effects on potassium balance.

Main Methods:

• Review of physiological mechanisms governing potassium regulation.
• Analysis of factors influencing potassium distribution between intracellular and extracellular fluids.
• Examination of drug interactions affecting renal potassium excretion and cellular uptake.

Main Results:

• Serum potassium is an unreliable indicator of total body potassium due to the small extracellular fraction.
• Renal potassium secretion is influenced by aldosterone, alkalosis, diet, and sodium delivery.
• Cellular potassium uptake is modulated by insulin, acid-base balance, aldosterone, and adrenergic activity.

Conclusions:

• Hypokalemia and hyperkalemia can arise from potassium redistribution, not just total body imbalances.
• Understanding drugs affecting potassium homeostasis is crucial for managing clinical potassium abnormalities.
• Both hypokalemia and hyperkalemia pose significant risks, including cardiac arrhythmias, muscle weakness, and potentially death.